Sponsor Pipeline

GC Biopharma Corp Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
9
Active Trials
5
Recruiting
3
Phase 3
1
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-27 NCT07728396 A Phase 1 Study to Evaluate the Safety and Immunogenicity of GC4006A in Healthy Adults Phase 1 Active, Not Recruiting
Active Trials by Phase
Phase 3
3
Phase 1/2
2
Phase 1
3
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05686759 A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of… Hepatitis B Recruiting
NCT07054099 A Study to Evaluate Immunogenicity and Safety After the First and Second Doses of MG1111… Varicella (Chickenpox) Recruiting
NCT04565015 Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary… Primary Immune Deficiency Active, Not Recruiting
Phase 1/2
NCT06997627 A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy Adults Tetanus-diphtheria-acellular Pertussis (Tdap) Recruiting
NCT06858397 A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients… Fabry Disesase Recruiting
Phase 1
NCT06567769 Phase 1 Study of GC1130A in Patients With Sanfilippo Syndrome Type A (MPS IIIA) Sanfilippo Syndrome Type A Recruiting
NCT05422482 A Study to Evaluate the Safety, Tolerability, PK and PD of Intracerebroventricular GC1123… Mucopolysaccharidosis II Active, Not Recruiting
NCT07728396 A Phase 1 Study to Evaluate the Safety and Immunogenicity of GC4006A in Healthy Adults COVID - 19 Active, Not Recruiting
Not specified
NCT07084246 Evaluation of the Effectiveness and Safety of Rozetel Tablet in Patients After PCI: A… Hypertension, Dyslipidemia Active, Not Recruiting
Disease Areas
Get alerts when GC Biopharma Corp's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free